Home > Insider Trading > Filing (0001593968-22-001691)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1771917	Karuna Therapeutics Inc.	KRTX	Pharmaceutical Preparations (2834)	270605902

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1777760	Craig Andrew Miller	C/O Karuna Therapeutics, Inc. 99 High Street, 26Th Floor Boston MA 02110	Chief Operating Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-12-02	250	$7.27	25,750	No	4	M	Direct
Common Stock	Acquisiton	2022-12-02	500	$2.92	26,250	No	4	M	Direct
Common Stock	Disposition	2022-12-01	15,000	$228.30	11,250	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option (right to buy)	Disposition	2022-12-02	250	$0.00	250	$7.27
Common Stock	Option (right to buy)	Disposition	2022-12-02	500	$0.00	500	$2.92

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
11,578		2028-08-08	No	4	M	Direct
54,917		2026-10-11	No	4	M	Direct

Footnotes

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2022.
This option vested as to 1/30th of the shares underlying the option award on each one month anniversary of the vesting commencement date of August 15, 2018.
This option vested as to 1/16th of the shares underlying the option award on the vesting commencement date of July 18, 2016 and as to an additional 1/16th of the shares on each three month anniversary thereafter.